AR
Anupam Rama JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Atara Biotherapeutics
ATRA
$85.5M
| $12.18 | $250 |
1,953%
upside
| Neutral |
13 Jul ‘22
3 years ago |
|
27
Cytokinetics
CYTK
$6.23B
| $52.09 | $58 |
11%
upside
| Overweight |
10 Dec ‘21
3 years ago |
|
28
Theravance Biopharma
TBPH
$701M
| $13.92 | $12 |
14%
downside
| Neutral |
5 Nov ‘21
3 years ago |
|
29
Vir Biotechnology
VIR
$721M
| $5.19 | $37 |
613%
upside
| Neutral |
25 Oct ‘21
3 years ago |
|
30
Protagonist Therapeutics
PTGX
$3.5B
| $56.19 | $55 |
2%
downside
| Overweight |
12 Oct ‘21
3 years ago |
|
31
Erasca
ERAS
$440M
| $1.55 | $28 |
1,706%
upside
| Overweight |
10 Aug ‘21
4 years ago |
|
32
Agios Pharmaceuticals
AGIO
$2.12B
| $36.41 | $54 |
48%
upside
| Neutral |
1 Mar ‘21
4 years ago |
|
33
Korro Bio
KRRO
$309M
| $32.92 | $2,800 |
8,405%
upside
| Overweight |
27 Jan ‘21
4 years ago |
|
34
BioAtla
BCAB
$35.9M
| $0.6112 | $45 |
7,263%
upside
| Overweight |
11 Jan ‘21
4 years ago |
|
35
Dyne Therapeutics
DYN
$1.89B
| $13.30 | $27 |
103%
upside
| Overweight |
12 Oct ‘20
4 years ago |
|
36
Alnylam Pharmaceuticals
ALNY
$59.6B
| $455.03 | $137 |
70%
downside
| Neutral |
7 May ‘20
5 years ago |
|